Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,511,833
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
40,117,934
-
Shares change
-
+16,968,689
-
Total reported value, excl. options
-
$102,301,880
-
Value change
-
+$40,961,743
-
Put/Call ratio
-
4.3%
-
Number of buys
-
37
-
Number of sells
-
26
-
Price
-
$2.55
Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q2 2024
As of 30 Jun 2024 Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) had 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 40,117,934 shares of stock of the company.
Largest 10 holders included Bain Capital Life Sciences Investors, LLC, VR Adviser, LLC, Casdin Capital, LLC, Boxer Capital, LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, DAFNA Capital Management LLC, Octagon Capital Advisors LP, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This table shows 75 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.